The US home healthcare market size was USD 171.60 billion in 2023, calculated at USD 194.24 billion in 2024 and is projected to surpass around USD 644.37 billion by 2034, expanding at a CAGR of 12.74% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: US Home Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. US Home Healthcare Market, by Type, 2024-2034
8.1.1 Device
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. US Home Healthcare Market, by Device, 2024-2034
9.1.1. Diagnostic & Monitoring Devices
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Therapeutic Devices
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Home Mobility Assist Devices
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. US Home Healthcare Market, by Services, 2024-2034
10.1.1. Rehabilitation
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Telehealth
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Respiratory Therapy
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Infusion Therapy
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Unskilled Homecare
10.1.5.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.2. Market Revenue and Forecast, by Device (2021-2034)
11.1.3. Market Revenue and Forecast, by Services (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Device (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Services (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Device (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Services (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.2. Market Revenue and Forecast, by Device (2021-2034)
11.2.3. Market Revenue and Forecast, by Services (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Device (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Services (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Device (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Services (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Device (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Services (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Device (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Services (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.2. Market Revenue and Forecast, by Device (2021-2034)
11.3.3. Market Revenue and Forecast, by Services (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Device (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Services (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Device (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Services (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Device (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Services (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Device (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Services (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.2. Market Revenue and Forecast, by Device (2021-2034)
11.4.3. Market Revenue and Forecast, by Services (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Device (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Services (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Device (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Services (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Device (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Services (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Device (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Services (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.2. Market Revenue and Forecast, by Device (2021-2034)
11.5.3. Market Revenue and Forecast, by Services (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Device (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Services (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Device (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Services (2021-2034)
12.1. Baxter International Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Abbott
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. ResMed Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. GE Healthcare
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Invacare Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Amedisys
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. LHC Group, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Medline Industries
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. BAYADA Home Health Care
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. F. Hoffmann-La Roche Ltd
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample